Annual Cash & Cash Equivalents
$134.34 M
+$5.03 M+3.89%
December 31, 2023
Summary
- As of February 8, 2025, HOWL annual cash & cash equivalents is $134.34 million, with the most recent change of +$5.03 million (+3.89%) on December 31, 2023.
- During the last 3 years, HOWL annual cash & cash equivalents has risen by +$41.77 million (+45.13%).
- HOWL annual cash & cash equivalents is now -14.72% below its all-time high of $157.53 million, reached on December 31, 2021.
Performance
HOWL Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$122.83 M
-$12.48 M-9.22%
September 30, 2024
Summary
- As of February 8, 2025, HOWL quarterly cash and cash equivalents is $122.83 million, with the most recent change of -$12.48 million (-9.22%) on September 30, 2024.
- Over the past year, HOWL quarterly cash and cash equivalents has dropped by -$7.23 million (-5.56%).
- HOWL quarterly cash and cash equivalents is now -32.97% below its all-time high of $183.23 million, reached on June 30, 2021.
Performance
HOWL Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
HOWL Cash And Cash Equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +3.9% | -5.6% |
3 y3 years | +45.1% | -5.0% |
5 y5 years | +650.7% | -5.0% |
HOWL Cash And Cash Equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -14.7% | +3.9% | -22.0% | at low |
5 y | 5-year | -14.7% | +650.7% | -33.0% | +45.2% |
alltime | all time | -14.7% | +650.7% | -33.0% | +45.2% |
Werewolf Therapeutics Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $122.83 M(-9.2%) |
Jun 2024 | - | $135.30 M(-2.8%) |
Mar 2024 | - | $139.19 M(+3.6%) |
Dec 2023 | $134.34 M(+3.9%) | $134.34 M(+3.3%) |
Sep 2023 | - | $130.06 M(-5.4%) |
Jun 2023 | - | $137.45 M(-7.0%) |
Mar 2023 | - | $147.87 M(+14.3%) |
Dec 2022 | $129.31 M | $129.31 M(-7.9%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2022 | - | $140.45 M(-3.6%) |
Jun 2022 | - | $145.71 M(+1.4%) |
Mar 2022 | - | $143.71 M(-8.8%) |
Dec 2021 | $157.53 M(+70.2%) | $157.53 M(-7.6%) |
Sep 2021 | - | $170.44 M(-7.0%) |
Jun 2021 | - | $183.23 M(+116.6%) |
Mar 2021 | - | $84.60 M(-8.6%) |
Dec 2020 | $92.57 M(+417.3%) | $92.57 M |
Dec 2019 | $17.90 M | - |
FAQ
- What is Werewolf Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Werewolf Therapeutics?
- What is Werewolf Therapeutics annual cash & cash equivalents year-on-year change?
- What is Werewolf Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Werewolf Therapeutics?
- What is Werewolf Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Werewolf Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of HOWL is $134.34 M
What is the all time high annual cash & cash equivalents for Werewolf Therapeutics?
Werewolf Therapeutics all-time high annual cash & cash equivalents is $157.53 M
What is Werewolf Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, HOWL annual cash & cash equivalents has changed by +$5.03 M (+3.89%)
What is Werewolf Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of HOWL is $122.83 M
What is the all time high quarterly cash and cash equivalents for Werewolf Therapeutics?
Werewolf Therapeutics all-time high quarterly cash and cash equivalents is $183.23 M
What is Werewolf Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, HOWL quarterly cash and cash equivalents has changed by -$7.23 M (-5.56%)